This study aimed to evaluate the association between the Mallampati score and other anatomical indicators, including maximal mouth opening and body mass index (BMI). We also evaluated the association between the Mallampati score and the apnea-hypopnea index (AHI) to confirm the scores' validity in predicting obstructive sleep apnea (OSA). Methods: We recruited patients with confirmed OSA who visited JR Tokyo General Hospital for oral appliance therapy between January 2016 and June 2019. The coefficients of determination were calculated by ordinary least square regression to evaluate the association between (a) the Mallampati score and maximal mouth opening, (b) AHI and BMI, and (c) the Mallampati score and AHI.
Results:We included 82 patients with an average (standard deviation) Mallampati score of 2.2 (0.9) and mouth opening capacity of 48.7 (6.5) mm. The Mallampati score was inversely associated with maximal mouth opening (R 2 = 0.189, P < .01). A higher BMI was associated with a higher AHI (R 2 = 0.115, P < .01). No significant association was found between the Mallampati score and the AHI (R 2 = 0.01, P = .33).
Conclusion:Although we were not able to confirm the association between the Mallampati score and the AHI that was reported previously, the Mallampati score was found to be inversely associated with the extent of mouth opening. K E Y W O R D S apnea-hypopnea index, body mass index, Mallampati score, maximal mouth opening, sleep apnea syndrome How to cite this article: Yonenaga K, Taga H, Eno Y, et al. Association between the Mallampati score and maximal mouth opening in patients with obstructive sleep apnea. Oral
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.